Scroll to top
Tag: diabetes

From Ideas to Impact: Symposium on Digital Therapeutics

Article Excerpt: The Clinically-Validated Digital Therapeutics: Innovations in Scientific Discovery, Clinical Applications, and Global Deployment event convened health care leaders across academia, government, and industry at the Hanover Inn on Oct. 25. Hosted by the Center for Technology and Behavioral Health, the digital heath summit, now in its second edition, is the only one of its kind situated in an academic institution. Besides clinical and computer science researchers, it brings together diverse stakeholders—providers, regulators, payers, and investors, as well as representatives from global pharma—to create pathways for translating ideas in the space of digital health to impact. In her welcoming remarks at the event President Sian Leah Beilock emphasized the urgency in realizing the potential of digital health in tackling mental health issues and other areas of health care.

Full Article:

Article Source: Dartmouth News


Glucose Data Reveals Seasonal Patterns in Diabetes Care

Article Excerpt: People with diabetes tend to maintain healthier blood sugar levels in the warmer months from April to September, according to a Dartmouth study published on Friday in Science Advances. The researchers accessed data from wearable glucose monitors that showed how 137 people aged 2 to 76 living primarily with type 1, aka juvenile, diabetes managed their blood sugar on a daily basis. By analyzing more than 91,000 days of data, the study provides the most detailed look yet at how diabetes management can vary by month, day, age, and even how experienced a patient is with the condition. “We’re looking for specific patterns that could potentially inform clinical guidelines and set the stage for targeted interventions,” says Temiloluwa Prioleau, assistant professor of computer science, one of the study co-authors.

Full Article:

Article Source: Dartmouth News


FDA Clears Prescription Digital Behavioral Therapeutic for Type 2 Diabetes

Article Excerpt: The Food and Drug Administration (FDA) has cleared AspyreRx™, a prescription digital behavioral therapeutic device for adults with type 2 diabetes.The device is intended to provide cognitive behavioral therapy (CBT), as an adjunct to standard of care, to patients aged 18 years and older with type 2 diabetes under the care of a health care provider. Prescribed in 90-day increments, the digital therapeutic delivers CBT through a mobile application in a weekly, step-by-step process to help patients improve glycemic control.

Full Article:

Article Source: Psychiatry Advisor


Cognitive Behavioral Therapy Mobile App Improves Health Behavior in Patients with Diabetes

Article Excerpt: With the use of cognitive behavioral therapy, a smartphone app helped patients with type 2 diabetes reduce HbA1c with less medication and insulation intensification vs. controls, a speaker reported. “Cardiometabolic diseases, and at its core, type 2 diabetes, are largely behavioral-acquired diseases and they’re related to unhelpful behaviors. But when we drive to what are the core, root causes of these behavioral choices, they have to do with thoughts and beliefs that lead to unhelpful behaviors and then unhelpful food choices, eating, exercise or behaviors and then type 2 diabetes,” Marc P. Bonaca, MD, MPH, FAHA, FACC, executive director of CPC Clinical Research, professor of cardiology and vascular medicine and director of vascular research at the University of Colorado School of Medicine, said during a press conference. “How do we break that cycle?

Full Article:

Article Source: Healio


Leveraging Data From Wearable Medical Devices

Article Excerpt: Diabetes, and other chronic conditions like cancer or cardiovascular disease, require a lifetime of management. In recent years, a slew of wearable devices such as glucose monitors, activity trackers, heart rate monitors, and pulse oximeters have been adopted by patients and health care providers to track and manage these conditions more effectively. These devices are also a rich source of data that can be analyzed to better understand the factors and behaviors that lead to improved health outcomes. “But they’re vastly underutilized,” says Temiloluwa Prioleau, assistant professor of computer science and co-director of the Augmented Health Lab, which is focused on bridging this gap.

Full Article:

Article Source: Dartmouth News


Dealing with Medication-Related Weight Gain

Article Excerpt: Part of taking medications is knowing there may be side effects and talking to your doctor if they’re anything worse than mild. But there is one somewhat common side effect that many people find especially worrisome: weight gain. Few among us want to gain weight—and extra pounds are particularly distressing if they further complicate the condition for which you’re taking the medicine in the first place. Some drugs prescribed to treat heart disease, type 2 diabetes, depression and arthritis can cause weight gain, which can make the disease they are treating worse instead of better, says UNC Health geriatrician and obesity medicine specialist John A. Batsis, MD.

Full Article:

Article Source: UNC Health Talk


Impact of telephone support programme using telemonitoring on stage of change towards healthy eating and active exercise in people with prediabetes

Sakane N, Oshima Y, Kotani K, Suganuma A, Takahashi K, Sato J, Suzuki S, Izumi K, Kato M, Noda M, Kuzuya H. (2021). Impact of telephone support programme using telemonitoring on stage of change towards healthy eating and active exercise in people with prediabetes. Journal of Telemedicine and Telecare, 27(5), 307–313.

A study evaluated the effectiveness of a telephone support program on healthy eating and exercise among adults with prediabetes. A total of 2607 participants (ages 20-65) with fasting plasma glucose level of 100-125 mg/dL was recruited from 43 health examination centers in Japan. The health examination centers were randomly assigned to a telephone support intervention based on stage of change framework or a control group that received health education newsletters. The intervention included healthcare providers and dieticians who assessed the participants’ lifestyle, health, and knowledge of diabetes. The providers and dieticians coached the participants through making goals, discussing the pros and cons of health behavior changes, identifying barriers to health behavior changes, and problem solving. The participants received the intervention for one year by telephone and five to six phone calls during the program. There are five stages of change: pre-contemplation (no intent to act), contemplation (intent to take action in next month), preparation (intent and some behavioral steps in this direction), action (behavior change for six months or less), and maintenance (behavior change for more than six months). The researchers collected participant data from a provided weight scale and pedometer monthly in both groups. The study found that the intervention significantly progressed the stage of change for healthy eating but not for active exercise. The intervention was most effective for participants at the contemplation stage relative to other stages, specifically on fasting plasma glucose level and blood pressure.


A web-delivered multicomponent intervention for adolescents with poorly controlled type 1 diabetes: A pilot randomized controlled trial

Stanger C, Lansing A, Scherer E, et al. (2018). A web-delivered multicomponent intervention for adolescents with poorly controlled type 1 diabetes: A pilot randomized controlled trial. Annals of Behavioral Medicine. 52(12): 1010–1022. doi: 10.1093/abm/kay005

Researchers compared effects of a web-delivered intervention, WebRx, to usual care (UC) on blood glucose monitoring behavior over 6 months among adolescents with poorly controlled type 1 diabetes (HbA1c ≥ 8%) and their parents. Read More


Juvenile Diabetes Often Catches Young Adults Unaware

Article Excerpt: Dartmouth College’s Center for Technology and Behavioral Health has been awarded $712,837 in federal funding to support the first of a five-year research study to test new ways to better treat and control Type 1 diabetes. Dr. Catherine Stanger is the principal investigator; researchers will start recruiting 300 participants in October.

Full Article:

Article Source: Union Leader